| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 86 | 100 | 106 | 109 | 94 | 110 | 97 | 150 | 67 | 95 | 111 | 122 | 128 | 124 | 125 | 211 | 119 | 125 | 126 | 131 | 147 | 145 | 146 | 166 | 132 | 163 | 134 |
| Expenses | 86 | 96 | 100 | 94 | 86 | 94 | 89 | 75 | 70 | 86 | 96 | 122 | 121 | 117 | 116 | 122 | 120 | 118 | 119 | 119 | 133 | 127 | 124 | 121 | 120 | 141 | 120 |
| EBITDA | 0 | 4 | 6 | 15 | 9 | 15 | 8 | 75 | -3 | 9 | 15 | -1 | 7 | 7 | 9 | 90 | -1 | 6 | 7 | 12 | 14 | 18 | 22 | 45 | 12 | 22 | 15 |
| Operating Profit % | -0 % | 3 % | 5 % | 7 % | 9 % | 14 % | 8 % | -12 % | -4 % | 9 % | 13 % | -1 % | 5 % | 6 % | 7 % | 10 % | -3 % | 5 % | 5 % | 10 % | 9 % | 12 % | 15 % | 13 % | 8 % | 12 % | 10 % |
| Depreciation | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 6 | 6 | 6 | 22 | 7 | 8 | 7 | 10 | 6 | 5 | 6 | 6 | 5 | 5 | 6 | 5 | 3 | 4 | 7 | 8 | 6 | 8 | 8 | 8 | 8 | 10 | 10 |
| Profit Before Tax | -9 | -4 | -2 | -10 | -1 | 5 | -2 | 63 | -11 | 2 | 6 | -9 | -1 | -1 | 0 | 82 | -7 | -1 | -3 | 1 | 5 | 7 | 10 | 34 | 1 | 8 | 1 |
| Tax | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -9 | -4 | -2 | -10 | -1 | 5 | -2 | 62 | -11 | 2 | 6 | -9 | -1 | -1 | 0 | 83 | -7 | -1 | -3 | 1 | 5 | 7 | 10 | 34 | 1 | 8 | 1 |
| EPS in ₹ | -3.59 | -1.79 | 0.00 | -4.17 | -0.35 | 2.12 | -0.90 | 26.02 | -4.47 | 0.65 | 2.36 | -3.58 | -0.28 | -0.17 | 0.12 | 25.62 | -2.22 | -0.27 | -1.00 | 0.31 | 1.43 | 2.25 | 3.14 | 10.28 | 0.32 | 2.44 | 0.38 |
Wanbury
209.58
+5.24
(2.56%)
Market Cap
686.80 Cr
EPS
17.10
PE Ratio
36.01
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
323.53
52 Week low
123.00
PB Ratio
17.23
Debt to Equity
0.00
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,669.30 | 4,00,520.99 | 34.13 | 49,887.20 | 12.06 | 9,648 | 13.77 | 37.74 | |
| 5,978.30 | 1,58,705.08 | 76.14 | 8,184.00 | 0.89 | 1,600 | 64.53 | 51.57 | |
| 1,479.70 | 1,19,502.65 | 23.70 | 26,520.70 | 14.17 | 4,155 | 47.38 | 51.15 | |
| 3,095.95 | 1,04,781.02 | 56.64 | 10,785.70 | 11.59 | 1,656 | 13.54 | 45.77 | |
| 1,170.95 | 97,705.34 | 18.09 | 28,905.40 | 12.36 | 5,578 | 1.69 | 30.83 | |
| 2,348.45 | 96,889.27 | 47.77 | 10,615.60 | 19.57 | 1,942 | -16.38 | 39.42 | |
| 899.65 | 90,525.84 | 19.78 | 19,831.50 | 13.82 | 3,831 | 29.92 | 36.77 | |
| 1,977.50 | 90,213.07 | 31.46 | 20,141.50 | 19.94 | 1,936 | 38.82 | 38.83 | |
| 1,121.25 | 65,122.38 | 18.72 | 29,559.20 | 17.55 | 3,169 | -10.04 | 42.81 | |
| 29,429.65 | 62,535.95 | 47.37 | 6,097.20 | 10.80 | 1,201 | 16.01 | 61.56 |
Growth Rate
Revenue Growth
15.58 %
Net Income Growth
-638.46 %
Cash Flow Change
-79.90 %
ROE
532.13 %
ROCE
-198.22 %
EBITDA Margin (Avg.)
162.16 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 406 | 388 | 412 | 273 | 286 | 279 | 289 | 353 | 304 | 344 |
| Fixed Assets | 164 | 180 | 186 | 178 | 172 | 164 | 167 | 167 | 167 | 167 |
| Current Assets | 191 | 164 | 192 | 74 | 94 | 90 | 98 | 171 | 122 | 159 |
| Capital Work in Progress | 19 | 14 | 10 | 10 | 9 | 14 | 11 | 2 | 2 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 223 | 193 | 216 | 84 | 105 | 101 | 111 | 183 | 135 | 174 |
| Total Liabilities | 406 | 388 | 412 | 273 | 286 | 279 | 289 | 353 | 304 | 344 |
| Current Liabilities | 275 | 299 | 402 | 348 | 362 | 311 | 355 | 360 | 320 | 214 |
| Non Current Liabilities | 298 | 251 | 163 | 109 | 134 | 111 | 90 | 16 | 16 | 101 |
| Total Equity | -167 | -162 | -153 | -185 | -209 | -144 | -156 | -23 | -33 | 28 |
| Reserve & Surplus | -214 | -221 | -177 | -208 | -233 | -168 | -181 | -56 | -66 | -11 |
| Share Capital | 20 | 20 | 23 | 24 | 24 | 25 | 25 | 33 | 33 | 33 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 5 | -5 | 3 | -2 | -0 | -0 | 7 | 13 | -21 | 2 |
| Investing Activities | -5 | -20 | -13 | -1 | -3 | 64 | 8 | 1 | -9 | -17 |
| Operating Activities | 40 | 43 | 43 | 33 | 30 | 44 | 17 | 41 | 20 | 4 |
| Financing Activities | -30 | -28 | -27 | -33 | -27 | -108 | -17 | -29 | -32 | 15 |
Share Holding
| % Holding | Mar 2021 | Apr 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 52.09 % | 39.93 % | 39.90 % | 39.90 % | 39.89 % | 39.89 % | 39.85 % | 39.85 % | 39.84 % | 39.84 % | 39.84 % | 39.80 % | 39.79 % | 39.79 % | 39.79 % | 39.77 % | 39.76 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.18 % | 0.22 % | 1.02 % | 0.84 % |
| DIIs | 1.13 % | 0.53 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.13 % | 0.13 % | 0.13 % | 0.13 % | 0.00 % | 0.13 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 1.04 % | 0.00 % | 0.00 % | 1.04 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 27.26 % | 44.39 % | 37.76 % | 38.04 % | 37.90 % | 38.16 % | 38.43 % | 38.67 % | 38.10 % | 37.83 % | 38.42 % | 39.53 % | 39.10 % | 41.81 % | 41.42 % | 40.66 % | 39.61 % |
| Others | 19.52 % | 14.12 % | 22.33 % | 22.05 % | 21.18 % | 21.96 % | 21.72 % | 21.35 % | 21.93 % | 22.20 % | 21.61 % | 20.67 % | 20.98 % | 18.22 % | 18.57 % | 18.54 % | 19.79 % |
| No of Share Holders | 11,831 | 11,724 | 11,748 | 11,581 | 11,619 | 11,289 | 11,398 | 11,555 | 11,888 | 11,911 | 11,741 | 11,634 | 11,616 | 13,087 | 14,400 | 17,199 | 17,999 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Intimation Under Regulation 30 And Schedule III Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 On Appointment Of Mr. Manojkumar Khubchand Gursahani (DIN: 01064558) And Mr
Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under Regulation 30 (LODR)-Change in Management
Shareholder Meeting / Postal Ballot-Outcome of EGM
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Revised Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.
Integrated Filing (Financial)
Announcement under Regulation 30 (LODR)-Raising of Funds
Integrated Filing (Financial)
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.
Board Meeting Outcome for Outcome Of Board Meeting Held On 121H February 2025 In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations
Board Meeting Intimation for Notice Of Board Meeting For Approving The Un-Audited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024 And Fund Raising.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Notice Of Book Closure For The Purpose Of Extra-Ordinary General Meeting (EOGM)
Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice Of The Extra Ordinary General Meeting Of Wanbury Limited
Announcement under Regulation 30 (LODR)-Newspaper Publication
Appointment Of Mr. Pallavur Sankar Dass Vaidyanathan And Mr. Manoj Gursahani As An Additional (Non-Executive Independent) Directors.
Announcement under Regulation 30 (LODR)-Change in Directorate
Disclosure under Regulation 30A of LODR
Announcement under Regulation 30 (LODR)-Change in Management
Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th January 2025 In Accordance With Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requi
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Closure of Trading Window
Technical Indicators
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
